{"seq": 1, "variant": "control", "cmd": "pm search --max 500 FES PET imaging lobular breast cancer", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40914389\n40813238\n40761268\n40369385\n40300962\n40067459\n40035673\n39438056\n39385362\n39058489\n38427956\n38365547\n38117098\n38071554\n37239021\n36919879\n36879065\n36243494\n36083216\n35681669\n34545689\n32680923\n32374053\n28604479\n27607175\n25693420\n17515338\n", "stderr": "", "elapsed_s": 0.867, "ts": 1771593260.109427}
{"seq": 2, "variant": "control", "cmd": "pm search --max 500 FES PET imaging lobular breast cancer", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40914389\n40813238\n40761268\n40369385\n40300962\n40067459\n40035673\n39438056\n39385362\n39058489\n38427956\n38365547\n38117098\n38071554\n37239021\n36919879\n36879065\n36243494\n36083216\n35681669\n34545689\n32680923\n32374053\n28604479\n27607175\n25693420\n17515338\n", "stderr": "", "elapsed_s": 0.861, "ts": 1771593272.4097736}
{"seq": 3, "variant": "control", "cmd": "pm search --max 500 FES PET imaging lobular breast cancer", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40914389\n40813238\n40761268\n40369385\n40300962\n40067459\n40035673\n39438056\n39385362\n39058489\n38427956\n38365547\n38117098\n38071554\n37239021\n36919879\n36879065\n36243494\n36083216\n35681669\n34545689\n32680923\n32374053\n28604479\n27607175\n25693420\n17515338\n", "stderr": "", "elapsed_s": 0.886, "ts": 1771593284.421906}
{"seq": 4, "variant": "control", "cmd": "pm fetch -v", "exit_code": 0, "stdin_lines": 29, "stdout": "<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2025//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd\">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">41319353</PMID><DateCompleted><Year>2026</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2026</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1938-0666</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2026</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Clinical breast cancer</Title><ISOAbbreviation>Clin Breast Cancer</ISOAbbreviation></Journal><ArticleTitle>Staging Invasive Lobular Carcinoma: A Prospective Study on the Efficacy of 18F-Fluoroestradiol (FES)-PET/CT.</ArticleTitle><Pagination><StartPage>36</StartPage><EndPage>46</EndPage><MedlinePgn>36-46</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.clbc.2025.11.003</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S1526-8209(25)00322-2</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Invasive lobular carcinoma (ILC) often presents diagnostic challenges on conventional imaging, necessitating advanced imaging strategies for accurate staging. [18F]Fluoroestradiol (FES), a PET radiopharmaceutical, targets estrogen receptor-positive (ER+) lesions, which are prevalent in ILC. This study evaluates the utility of FES-PET/CT compared to standard-of-care (SOC) imaging for staging ER+ ILC.</AbstractText><AbstractText Label=\"PATIENTS AND METHODS\" NlmCategory=\"METHODS\">This IRB-approved prospective trial (October 2022-October 2024) enrolled adults with histologically confirmed ER+ ILC at a National Cancer Institute-designated Comprehensive Cancer Center. Participants underwent FES-PET/CT, with optional [18F]Fluorodeoxyglucose (FDG)-PET/CT. The primary endpoint was the percentage ", "stderr": "Fetching batch 1 (29 PMIDs)...\n", "elapsed_s": 1.029, "ts": 1771593285.4630902}
{"seq": 5, "variant": "control", "cmd": "pm parse -v 2", "exit_code": 0, "stdin_lines": 50, "stdout": "", "stderr": "", "elapsed_s": 0.376, "ts": 1771593285.8493283}
{"seq": 6, "variant": "control", "cmd": "pm filter --year 2020- --has-abstract", "exit_code": 0, "stdin_lines": 0, "stdout": "", "stderr": "", "elapsed_s": 0.357, "ts": 1771593293.1402752}
{"seq": 7, "variant": "control", "cmd": "pm search --max 500 FES PET imaging lobular breast cancer", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40914389\n40813238\n40761268\n40369385\n40300962\n40067459\n40035673\n39438056\n39385362\n39058489\n38427956\n38365547\n38117098\n38071554\n37239021\n36919879\n36879065\n36243494\n36083216\n35681669\n34545689\n32680923\n32374053\n28604479\n27607175\n25693420\n17515338\n", "stderr": "", "elapsed_s": 0.697, "ts": 1771593322.598545}
{"seq": 8, "variant": "control", "cmd": "pm search FES PET imaging breast cancer --max 500", "exit_code": 0, "stdin_lines": 0, "stdout": "41532824\n41344861\n41319353\n41275454\n41275453\n41186678\n40976009\n40968016\n40941628\n40914389\n40813238\n40791606\n40761268\n40682675\n40569557\n40539912\n40474373\n40427142\n40369385\n40314583\n40300962\n40179297\n40179295\n40127051\n40081952\n40067459\n40035673\n39962532\n39900666\n39848768\n39848225\n39806206\n39613672\n39518426\n39506820\n39440077\n39438056\n39423781\n39401324\n39385365\n39385362\n39368910\n39362758\n39123367\n39058489\n39011728\n38993095\n38929989\n38786300\n38743917\n38548518\n38436824\n38427956\n38423389\n38365547\n38338854\n38302151\n38177052\n38117098\n38107829\n38105347\n38071554\n37805387\n37787851\n37620179\n37568977\n37566798\n37482660\n37433673\n37296702\n37270377\n37261814\n37239021\n37223262\n36988617\n36919879\n36879065\n36863779\n36821506\n36800243\n36769616\n36735488\n36620595\n36243494\n36165348\n36093891\n36083216\n36028895\n35884590\n35797633\n35717099\n35681669\n35675139\n35584346\n35492341\n35464670\n35448720\n35407526\n35379454\n35362795\n35119664\n35116468\n34988456\n34829366\n34725978\n34545689\n34476181\n34446451\n34392915\n34319950\n34139575\n34031720\n33990400\n33737962\n33576480\n33369181\n33354178\n33251143\n33181752\n32993099\n32912274\n32859700\n32718075\n32699974\n32680923\n32627087\n32601772\n32591490\n32448947\n32374053\n32307594\n32272493\n32229068\n32174461\n32111662\n31891878\n31723360\n31337657\n31281233\n31016232\n30850489\n30846327\n30833270\n30324461\n30176563\n30100079\n29956818\n29755845\n29731987\n29602822\n29488712\n29485433\n29478216\n29466767\n29298808\n29298807\n28956736\n28912144\n28798032\n28747642\n28604479\n28553180\n28221191\n28011460\n27872957\n27863565\n27774910\n27607175\n27739102\n27688475\n27647983\n27491481\n27467716\n27342400\n27307345\n26850484\n26834109\n26091705\n25880006\n25829085\n25693420\n25617853\n25609068\n25520392\n25476421\n25380844\n25375016\n24205151\n24170452\n24079874\n23970364\n23949891\n23787040\n23762549\n23725994\n23619898\n23105956\n22749433\n22669982\n22379639\n22337690\n22241912\n22079037\n21982568\n21750198\n21204318\n19914546\n20641704\n20641441\n18327670\n18287268\n18250990\n17920354\n17718929\n17718061\n17515338\n17499736\n17156828\n16963265\n16682724\n15246367\n15127240\n12123788\n11387350\n11337559\n10708304\n10096512\n99336", "stderr": "", "elapsed_s": 0.749, "ts": 1771593471.6598177}
{"seq": 9, "variant": "control", "cmd": "pm fetch -v", "exit_code": 0, "stdin_lines": 235, "stdout": "<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2024//EN\"\n \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd\">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">41532824</PMID><DateRevised><Year>2026</Year><Month>01</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1536-0229</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2026</Year><Month>Jan</Month><Day>14</Day></PubDate></JournalIssue><Title>Clinical nuclear medicine</Title><ISOAbbreviation>Clin Nucl Med</ISOAbbreviation></Journal><ArticleTitle>[18F]Fluoroestradiol Uptake in Benign Nodular Sclerosing Adenosis of the Breast.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1097/RLU.0000000000006332</ELocationID><Abstract><AbstractText>A 70-year-old woman with estrogen receptor-positive (ER+) invasive ductal carcinoma (IDC) of the right breast underwent 18F-fluoroestradiol (18F-FES) PET/CT demonstrating uptake in the IDC (SUVmax 2.5) and also extensive 18F-FES uptake in bilateral breasts corresponding to marked bilateral background enhancement on MRI. MRI-guided biopsy of a representative enhancing 18F-FES-avid region in the left breast (SUVmax 3.5) revealed nodular sclerosing adenosis without cellular atypia or malignancy, but with 30% ER positivity on immunohistochemistry. False-positive uptake of 18F-FES is reported in irradiated lung and interstitial lung disease. This case highlights another mechanism of false-positive 18F-FES uptake due to ER overexpression in benign breast tissue.</AbstractText><CopyrightInformation>Copyright \u00a9 2026 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Lawal</LastName><ForeName>Ismaheel O</ForeName><Initials>IO</Initials><AffiliationInfo><Affiliation>Department of Radiology and Imaging Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><Las", "stderr": "Fetching batch 1 (200 PMIDs)...\nFetching batch 2 (35 PMIDs)...\n", "elapsed_s": 2.571, "ts": 1771593481.8892858}
{"seq": 10, "variant": "control", "cmd": "pm parse -v 2", "exit_code": 0, "stdin_lines": 1071, "stdout": "", "stderr": "", "elapsed_s": 0.301, "ts": 1771593482.2282567}
{"seq": 11, "variant": "control", "cmd": "pm fetch", "exit_code": 0, "stdin_lines": 3, "stdout": "<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2025//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd\">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">41532824</PMID><DateRevised><Year>2026</Year><Month>01</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1536-0229</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2026</Year><Month>Jan</Month><Day>14</Day></PubDate></JournalIssue><Title>Clinical nuclear medicine</Title><ISOAbbreviation>Clin Nucl Med</ISOAbbreviation></Journal><ArticleTitle>[18F]Fluoroestradiol Uptake in Benign Nodular Sclerosing Adenosis of the Breast.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1097/RLU.0000000000006332</ELocationID><Abstract><AbstractText>A 70-year-old woman with estrogen receptor-positive (ER+) invasive ductal carcinoma (IDC) of the right breast underwent 18F-fluoroestradiol (18F-FES) PET/CT demonstrating uptake in the IDC (SUVmax 2.5) and also extensive 18F-FES uptake in bilateral breasts corresponding to marked bilateral background enhancement on MRI. MRI-guided biopsy of a representative enhancing 18F-FES-avid region in the left breast (SUVmax 3.5) revealed nodular sclerosing adenosis without cellular atypia or malignancy, but with 30% ER positivity on immunohistochemistry. False-positive uptake of 18F-FES is reported in irradiated lung and interstitial lung disease. This case highlights another mechanism of false-positive 18F-FES uptake due to ER overexpression in benign breast tissue.</AbstractText><CopyrightInformation>Copyright &#xa9; 2026 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Lawal</LastName><ForeName>Ismaheel O</ForeName><Initials>IO</Initials><AffiliationInfo><Affiliation>Department of Radiology and Imaging Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\">", "stderr": "", "elapsed_s": 0.771, "ts": 1771593857.284478}
{"seq": 12, "variant": "control", "cmd": "pm parse", "exit_code": 0, "stdin_lines": 75, "stdout": "{\"pmid\": \"41532824\", \"title\": \"[18F]Fluoroestradiol Uptake in Benign Nodular Sclerosing Adenosis of the Breast.\", \"authors\": [\"Lawal Ismaheel O\", \"Seidel Rebecca\", \"Li Xiaoxian\", \"Nayar Jemimah\", \"Mankoff David A\", \"Schuster David M\"], \"journal\": \"Clinical nuclear medicine\", \"year\": \"2026\", \"date\": \"2026-01-14\", \"abstract\": \"A 70-year-old woman with estrogen receptor-positive (ER+) invasive ductal carcinoma (IDC) of the right breast underwent 18F-fluoroestradiol (18F-FES) PET/CT demonstrating uptake in the IDC (SUVmax 2.5) and also extensive 18F-FES uptake in bilateral breasts corresponding to marked bilateral background enhancement on MRI. MRI-guided biopsy of a representative enhancing 18F-FES-avid region in the left breast (SUVmax 3.5) revealed nodular sclerosing adenosis without cellular atypia or malignancy, but with 30% ER positivity on immunohistochemistry. False-positive uptake of 18F-FES is reported in irradiated lung and interstitial lung disease. This case highlights another mechanism of false-positive 18F-FES uptake due to ER overexpression in benign breast tissue.\", \"doi\": \"10.1097/RLU.0000000000006332\"}\n{\"pmid\": \"41344861\", \"title\": \"The Role of Estrogen Receptor-Targeted PET with 16\u03b1-18F-Fluoro-17\u03b2-Estradiol in Predicting Response to Endocrine Therapies in Metastatic Breast Cancer: A Metaanalysis.\", \"authors\": [\"Specht Jennifer M\", \"van Geel Jasper J L\", \"Song Shaoli\", \"Liu Cheng\", \"Hippe Daniel S\", \"DiGregorio Nicholas A\", \"Brand Christine J\", \"Linden Hannah M\"], \"journal\": \"Journal of nuclear medicine : official publication, Society of Nuclear Medicine\", \"year\": \"2026\", \"date\": \"2026-01-02\", \"abstract\": \"[18F]16\u03b1-fluoro-17\u03b2-fluoroestradiol ([18F]FES) PET/CT imaging enables whole-body assessment of functional estrogen receptor (ER) expression in metastatic breast cancer (mBC). Identifying imaging biomarkers that predict endocrine therapy (ET) response remains a critical need in optimizing treatment selection. Our objective was to assess the predictive utility of [18F]FES PET/CT imaging in determin", "stderr": "", "elapsed_s": 0.23, "ts": 1771593862.5313208}
{"seq": 13, "variant": "control", "cmd": "pm parse -v 2", "exit_code": 0, "stdin_lines": 0, "stdout": "", "stderr": "", "elapsed_s": 0.249, "ts": 1771593869.2266011}
{"seq": 14, "variant": "control", "cmd": "pm fetch -v 2", "exit_code": 0, "stdin_lines": 235, "stdout": "<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2024//EN\"\n \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd\">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">41532824</PMID><DateRevised><Year>2026</Year><Month>01</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1536-0229</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2026</Year><Month>Jan</Month><Day>14</Day></PubDate></JournalIssue><Title>Clinical nuclear medicine</Title><ISOAbbreviation>Clin Nucl Med</ISOAbbreviation></Journal><ArticleTitle>[18F]Fluoroestradiol Uptake in Benign Nodular Sclerosing Adenosis of the Breast.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1097/RLU.0000000000006332</ELocationID><Abstract><AbstractText>A 70-year-old woman with estrogen receptor-positive (ER+) invasive ductal carcinoma (IDC) of the right breast underwent 18F-fluoroestradiol (18F-FES) PET/CT demonstrating uptake in the IDC (SUVmax 2.5) and also extensive 18F-FES uptake in bilateral breasts corresponding to marked bilateral background enhancement on MRI. MRI-guided biopsy of a representative enhancing 18F-FES-avid region in the left breast (SUVmax 3.5) revealed nodular sclerosing adenosis without cellular atypia or malignancy, but with 30% ER positivity on immunohistochemistry. False-positive uptake of 18F-FES is reported in irradiated lung and interstitial lung disease. This case highlights another mechanism of false-positive 18F-FES uptake due to ER overexpression in benign breast tissue.</AbstractText><CopyrightInformation>Copyright \u00a9 2026 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Lawal</LastName><ForeName>Ismaheel O</ForeName><Initials>IO</Initials><AffiliationInfo><Affiliation>Department of Radiology and Imaging Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><Las", "stderr": "Fetching batch 1 (200 PMIDs)...\nFetching batch 2 (35 PMIDs)...\n", "elapsed_s": 3.233, "ts": 1771593872.217428}
